Editing Unlearn AI

{{Company
|name=Unlearn AI
|location=San Francisco, US
|category=AI Drug Discovery & Genomics
|founded=2017
|funding=$50M+
|website=https://www.unlearn.ai
}}

== What They Do ==
Generates AI digital twins from clinical data to optimize clinical trials. Uses patient longitudinal data for prediction and generates synthetic control arms, reducing trial sizes and timelines.

== AIDAVA Relevance ==
Longitudinal patient data for digital twins, synthetic data generation

== Funding ==
'''Valuation:''' ~$200M+ (est.)
$50M+

== Business Details ==
* '''Founded:''' 2019
* '''Total Funding:''' $50M Series C
* '''Valuation:''' ~$200M+ (est.)
* '''Revenue:''' N/A (private)
* '''Employees:''' ~50-100 (est.)
* '''Key Milestones:''' $50M Series C. Digital twins for clinical trials. Applied to VectorY PIONEER-ALS study.

== See Also ==
* [[AIDAVA Competitive Analysis]]
* [[Triall]]
* [[AIDAVA]]
* [[AIDAVA Related Companies]]
* [[Interoperability]]

[[Category:Company]]
[[Category:San Francisco]]